Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,268
Total Claims
$895K
Drug Cost
398
Beneficiaries
$2,248
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+29%
Opioid rate vs peers
3.3% vs 2.6% avg
+111%
Cost per patient vs peers
$2,248 vs $1,068 avg
+48%
Brand preference vs peers
13.4% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
3.3%
Opioid Rate
374
Opioid Claims
$2,378
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,490 claims · $763K
Generic: 9,663 claims · $126K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Sitagliptin Phosphate | 127 | $107K |
| Semaglutide | 96 | $99K |
| Linaclotide | 152 | $70K |
| Apixaban | 103 | $54K |
| Tirzepatide | 46 | $52K |
| Fluticasone/Umeclidin/Vilanter | 62 | $50K |
| Empagliflozin | 34 | $32K |
| Methylnaltrexone Bromide | 29 | $28K |
| Insulin Glargine,hum.Rec.Anlog | 33 | $25K |
| Dapagliflozin Propanediol | 28 | $22K |
| Linagliptin | 27 | $20K |
| Mirabegron | 58 | $18K |
| Insulin Glargine,hum.Rec.Anlog | 39 | $18K |
| Sitagliptin Phos/Metformin Hcl | 29 | $15K |
| Rivaroxaban | 18 | $10K |
Prescribing Profile
Patient Profile
70
Avg Age
67%
Female
1.19
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About